[go: up one dir, main page]

DK1181027T3 - Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri - Google Patents

Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri

Info

Publication number
DK1181027T3
DK1181027T3 DK00935478T DK00935478T DK1181027T3 DK 1181027 T3 DK1181027 T3 DK 1181027T3 DK 00935478 T DK00935478 T DK 00935478T DK 00935478 T DK00935478 T DK 00935478T DK 1181027 T3 DK1181027 T3 DK 1181027T3
Authority
DK
Denmark
Prior art keywords
hyperoxaluria
dietetic
prevention
treatment
pharmaceutical preparation
Prior art date
Application number
DK00935478T
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Actial Farmaceutica Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actial Farmaceutica Lda filed Critical Actial Farmaceutica Lda
Application granted granted Critical
Publication of DK1181027T3 publication Critical patent/DK1181027T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK00935478T 1999-05-28 2000-05-24 Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri DK1181027T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000338A IT1309427B1 (it) 1999-05-28 1999-05-28 Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso

Publications (1)

Publication Number Publication Date
DK1181027T3 true DK1181027T3 (da) 2004-08-16

Family

ID=11406789

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00935478T DK1181027T3 (da) 1999-05-28 2000-05-24 Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri

Country Status (34)

Country Link
US (2) US6562336B2 (da)
EP (1) EP1181027B1 (da)
JP (1) JP4737836B2 (da)
KR (1) KR100781703B1 (da)
CN (1) CN100350919C (da)
AR (1) AR024555A1 (da)
AT (1) ATE265857T1 (da)
AU (1) AU773459B2 (da)
BR (1) BR0011038B1 (da)
CA (1) CA2373255C (da)
CZ (1) CZ20014076A3 (da)
DE (1) DE60010456T2 (da)
DK (1) DK1181027T3 (da)
DZ (1) DZ3165A1 (da)
EA (1) EA004257B1 (da)
EE (1) EE200100618A (da)
ES (1) ES2219344T3 (da)
HK (1) HK1048066B (da)
HU (1) HU225134B1 (da)
IL (3) IL146703A0 (da)
IS (1) IS6150A (da)
IT (1) IT1309427B1 (da)
MA (1) MA26790A1 (da)
MX (1) MXPA01012184A (da)
NO (1) NO20015782L (da)
NZ (1) NZ516020A (da)
PL (1) PL352014A1 (da)
PT (1) PT1181027E (da)
SI (1) SI1181027T1 (da)
SK (1) SK16612001A3 (da)
TR (1) TR200103439T2 (da)
UA (1) UA71621C2 (da)
WO (1) WO2000072855A2 (da)
ZA (1) ZA200110504B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
AU2004249060A1 (en) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. Composition for lowering serum uric acid level
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
JP2007529214A (ja) * 2004-03-19 2007-10-25 ダニスコ エイ／エス ショートニング用乳化剤組成物
EP1814995A2 (en) * 2004-10-27 2007-08-08 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
BRPI0611492B1 (pt) 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
AU2005339139A1 (en) 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
JP5558002B2 (ja) 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
WO2008119012A2 (en) * 2007-03-27 2008-10-02 The Procter & Gamble Company Methods and kits for administering probiotics
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CN101606952B (zh) * 2008-06-17 2012-09-19 上海交通大学医学院附属第三人民医院 乳双歧杆菌在制备预防泌尿系统结石药物中的应用
US9283252B2 (en) 2008-09-30 2016-03-15 Meiji Co., Ltd. Lactic acid bacterium having high oxalic acid decomposition ability
CN101554237B (zh) * 2009-03-16 2013-11-06 武汉康复得生物科技有限公司 植物纤维或微生物不溶组分中的草酸降解酶的制备方法
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110791A1 (it) * 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20121173A1 (it) * 2012-07-04 2014-01-05 Neupharma Srl Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
JP5765832B2 (ja) * 2013-12-26 2015-08-19 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤
PL3237600T3 (pl) * 2014-10-01 2020-11-16 Triphase Pharmaceuticals Pvt. Ltd. Termostabilne szczepy, ich produkty i sposoby stosowania
ITUB20155752A1 (it) * 2015-11-19 2017-05-19 Probiotical Spa Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
MA45334A (fr) 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
CN107868775A (zh) 2016-09-23 2018-04-03 武汉康复得生物科技股份有限公司 草酸脱羧酶的制备及其制品和应用
WO2018125735A1 (en) 2016-12-29 2018-07-05 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
AU2019396366A1 (en) * 2018-12-10 2021-07-15 Tenza, Inc. Methods and compositions for treating hyperoxaluria
US20230092431A1 (en) * 2020-01-14 2023-03-23 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders in which oxalate is detrimental
CN113308416B (zh) * 2021-07-20 2023-02-24 四川大学 一株具有抑制肾结石形成能力的植物乳杆菌及其应用
CN115851508B (zh) * 2022-10-13 2024-01-09 山东中科嘉亿生物工程有限公司 一种降草酸、改善肾结石的嗜热链球菌jyst-26及其产品、应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
DK0768375T4 (da) * 1992-07-06 2002-09-16 Nestle Sa Mælkesyrebakterier
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
EP0856259B1 (en) * 1996-12-23 1998-08-12 SITIA-YOMO S.p.A. Composition for feed use comprising lyophilized live lactic bacteria
DE69841200D1 (de) * 1997-05-23 2009-11-12 Oxthera Inc Oxalate-abbauende mikroorganismen oder oxalate-abbauende enzyme zur verhütung der oxalate-verwandten krankheiten
RU2139346C1 (ru) * 1999-03-02 1999-10-10 Шендеров Борис Аркадьевич Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для приготовления препаратов и продуктов питания для профилактики и лечения гипероксалурии

Also Published As

Publication number Publication date
US20020061292A1 (en) 2002-05-23
DZ3165A1 (fr) 2000-12-07
ZA200110504B (en) 2002-09-25
PL352014A1 (en) 2003-07-14
SK16612001A3 (sk) 2002-04-04
UA71621C2 (en) 2004-12-15
BR0011038B1 (pt) 2014-02-18
HUP0201409A2 (en) 2002-08-28
USRE39585E1 (en) 2007-04-24
AU773459B2 (en) 2004-05-27
EE200100618A (et) 2003-02-17
AU5101600A (en) 2000-12-18
DE60010456D1 (de) 2004-06-09
ES2219344T3 (es) 2004-12-01
WO2000072855A2 (en) 2000-12-07
HUP0201409A3 (en) 2004-10-28
JP2003500451A (ja) 2003-01-07
BR0011038A (pt) 2002-02-26
US6562336B2 (en) 2003-05-13
HK1048066B (zh) 2008-08-01
ITRM990338A1 (it) 2000-11-28
EP1181027B1 (en) 2004-05-06
JP4737836B2 (ja) 2011-08-03
CZ20014076A3 (cs) 2002-03-13
CA2373255A1 (en) 2000-12-07
HU225134B1 (en) 2006-06-28
EA200101262A1 (ru) 2002-04-25
MXPA01012184A (es) 2003-06-30
KR20020019918A (ko) 2002-03-13
CA2373255C (en) 2010-01-19
DE60010456T2 (de) 2005-05-12
HK1048066A1 (zh) 2003-03-21
NO20015782L (no) 2002-01-25
NZ516020A (en) 2003-06-30
ITRM990338A0 (it) 1999-05-28
IS6150A (is) 2001-11-08
ATE265857T1 (de) 2004-05-15
IT1309427B1 (it) 2002-01-23
EA004257B1 (ru) 2004-02-26
AR024555A1 (es) 2002-10-16
WO2000072855A3 (en) 2001-06-28
IL199437A0 (en) 2011-07-31
EP1181027A2 (en) 2002-02-27
NO20015782D0 (no) 2001-11-27
PT1181027E (pt) 2004-09-30
IL146703A (en) 2010-03-28
TR200103439T2 (tr) 2002-06-21
SI1181027T1 (en) 2004-08-31
IL199437A (en) 2016-10-31
KR100781703B1 (ko) 2007-12-03
IL146703A0 (en) 2002-07-25
MA26790A1 (fr) 2004-12-20
CN1365284A (zh) 2002-08-21
CN100350919C (zh) 2007-11-28

Similar Documents

Publication Publication Date Title
DK1181027T3 (da) Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
NO20016304L (no) Erytropoetinkonjugater med polyetylenglykol, fremstilling av slike konjugater, preparater omfattende slike konjugater samt anvendelse av slike konjugater for fremstilling av medikamenter for forebygging eller behandling av sykdom
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
IL202633A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
DK1117394T3 (da) Anvendelse af carnitiner og resveratrol til fremstilling af et præparat til forebyggelse eller terapeutisk behandling af cerabrale lidelser forårsaget af aldring og anvendelse af neurotoksiske medikamenter
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
NO995500L (no) Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
IS6378A (is) Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
DK1296705T3 (da) Beta-amyloid-oligomerer til anvendelse til behandling, lindring eller forebyggelse af Alzheimers sygdom
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
NO20020156D0 (no) Titanavledede forbindelser, fremstilling og anvendelse derav
NO20022022D0 (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20001905D0 (no) Forbindelser og deres anvendelse i farmasøytiske eller kosmetiske preparater
PL354413A1 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts ofginkgo biloba
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
DK1216035T3 (da) Tilberedning indeholdende aktive stoffer og/eller hjælpestoffer med kontrolleret frigivelse af disse stoffer og anvendelse og fremstilling deraf
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
PT1073431E (pt) Utlizacao de antagonistas de nmda no tratamento da sindroma do intestino irritavel
IT1306179B1 (it) Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ZA200006732B (en) Utilization of Aryl (or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation.
HUP0002154A3 (en) Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression
EE200200142A (et) Heterotsükliliselt asendatud bensoüülguanidiinid,nende saamine ja kasutamine ravimite valmistamiseks ning neid sisaldav ravim